Melanoma is a type of cancer that originates from melanocytes, the cells responsible for producing skin pigment, and is known ...

Key mechanism of resistance to BRAF-targeted melanoma therapy discovered. Potential for developing new cancer therapies with high efficacy by regulating polyamine biosynthesis to suppress resistance.

Patients with wild-type metastatic melanoma that progressed on frontline PD-1 inhibition had almost a 2-year median overall ...

Black Diamond Therapeutics has deprioritized one of its two clinical-stage lung cancer contenders, jettisoned two executives ...

The company presented three-year follow-up data from a Phase 2 study on Saturday looking at patients with BRAF V600E-mutant metastatic non-small cell lung cancer who received Braftovi and another ...

NEW YORK, Sept 14 (Reuters) - Pfizer (PFE.N), opens new tab is trying to increase doctor awareness of and testing for a rare lung cancer mutation to help boost use of its drug Braftovi, which the ...

This BRAF V600X degrader is currently in Phase 1 clinical trials and has shown encouraging results in preclinical studies and early clinical data. In April 2024, C4 Therapeutics presented ...

This BRAF V600X degrader is currently in Phase 1 clinical trials and has shown encouraging results in preclinical studies and early clinical data. In April 2024, C4 Therapeutics presented preclinical ...

The former cancer counsellor revealed she has a history of cervical cancer and had a hysterectomy in 2020 but after ...

The company presented three-year follow-up data from a Phase 2 study on Saturday looking at patients with BRAF V600E-mutant metastatic non-small cell lung cancer who received Braftovi and another ...